The Use of DHEA in Women With Premature Ovarian Failure

Virginia Center for Reproductive Medicine

Status and phase: Withdrawn; Early Phase 1

Conditions: Premature Ovarian Failure

Treatments: Drug: DHEA

Study type: Interventional

Funder types: Other

Identifiers

NCT01129947

VCRM4

Details and patient eligibility

About

DHEA supplementation has been used in women with infertility and diminished ovarian reserve. There is a small report in 5 women with POF that benefited from the use of DHEA over several months. The investigators aim to evaluate further the use of DHEA in women with Premature ovarian failure (POF).

Sex: Female

Ages: 18 to 40 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women with POF

Exclusion criteria

• women without ovaries

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 1 patient group

DHEA

Experimental group

Treatment:

Drug: DHEA